Literature DB >> 24220228

Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated in serial cultures from the respiratory tract of children with cystic fibrosis.

Duha Al-Zubeidi1, Patrick G Hogan, Mary Boyle, Carey-Ann D Burnham, Stephanie A Fritz.   

Abstract

BACKGROUND: Little is known about strain relatedness of methicillin-resistant Staphyloccocus aureus (MRSA) isolated at serial time points from the respiratory tract of patients with cystic fibrosis (CF). The objectives are to interrogate the genetic diversity of MRSA recovered in serial cultures from children with CF and to correlate strain relatedness with clinical characteristics.
METHODS: We performed a retrospective analysis of children with CF from whom MRSA was isolated from serial respiratory cultures from 2005 to 2011. Within individual patients, relatedness of isolated strains was determined by repetitive-sequence polymerase chain reaction, and the staphylococcal cassette chromosome mec type of each isolate was characterized. Medical records corresponding to the MRSA cultures were reviewed.
RESULTS: We identified 54 CF patients with serial MRSA cultures (145 distinct cultures). Over time, 45 (83%) patients maintained the same strain type and 9 (17%) possessed at least 2 distinct strain types. A total of 91 pairs of isolates were analyzed for strain relatedness. Of these, 81 (89%) were identical and 10 (11%) were distinct strain types. About 117 (83%) isolates were staphylococcal cassette chromosome mec type II, 24 (17%) were staphylococcal cassette chromosome mec type IV and 4 were other types not resolvable with our assay. Clinical factors, including time interval and prescription of antibiotics effective against MRSA between positive cultures, did not correlate with acquisition of a distinct MRSA strain by individual patients.
CONCLUSIONS: Our data suggest that sustained presence of MRSA in CF patients is most commonly attributable to identical strain types. Acquisition of distinct MRSA strains in the airway is infrequent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24220228      PMCID: PMC4016999          DOI: 10.1097/INF.0000000000000204

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  37 in total

1.  A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V.

Authors:  K Boye; M D Bartels; I S Andersen; J A Møller; H Westh
Journal:  Clin Microbiol Infect       Date:  2007-04-02       Impact factor: 8.067

2.  Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients.

Authors:  S Silbert; A L Barth; H S Sader
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 3.  Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis.

Authors:  Elliott C Dasenbrook
Journal:  Curr Opin Pulm Med       Date:  2011-11       Impact factor: 3.155

4.  Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.

Authors:  Stephanie A Fritz; Patrick G Hogan; Bernard C Camins; Ali J Ainsworth; Carol Patrick; Madeline S Martin; Melissa J Krauss; Marcela Rodriguez; Carey-Ann D Burnham
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

5.  Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis.

Authors:  Elliott C Dasenbrook; William Checkley; Christian A Merlo; Michael W Konstan; Noah Lechtzin; Michael P Boyle
Journal:  JAMA       Date:  2010-06-16       Impact factor: 56.272

6.  Staphylococcus aureus nasal colonization among pediatric cystic fibrosis patients and their household contacts.

Authors:  Anne Stone; Lynne Quittell; Juyan Zhou; Luis Alba; Meera Bhat; Joan DeCelie-Germana; Sujatha Rajan; Lynn Bonitz; John J Welter; Allen J Dozor; Ingrid Gherson; Franklin D Lowy; Lisa Saiman
Journal:  Pediatr Infect Dis J       Date:  2009-10       Impact factor: 2.129

7.  Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007.

Authors:  Kristina G Hultén; Sheldon L Kaplan; Linda B Lamberth; Katherine Slimp; Wendy A Hammerman; Maria Carrillo-Marquez; Jeffrey R Starke; James Versalovic; Edward O Mason
Journal:  Infect Control Hosp Epidemiol       Date:  2010-02       Impact factor: 3.254

8.  Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients.

Authors:  Eef Vanderhelst; Elke De Wachter; Julie Willekens; Denis Piérard; Walter Vincken; Anne Malfroot
Journal:  J Cyst Fibros       Date:  2013-05-21       Impact factor: 5.482

9.  Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.

Authors:  Clement L Ren; Wayne J Morgan; Michael W Konstan; Michael S Schechter; Jeffrey S Wagener; Kathryn A Fisher; Warren E Regelmann
Journal:  Pediatr Pulmonol       Date:  2007-06

10.  Presence of the bla(Z) beta-lactamase gene in isolates of Staphylococcus aureus that appear penicillin susceptible by conventional phenotypic methods.

Authors:  Rana E El Feghaly; Jennifer E Stamm; Stephanie A Fritz; Carey-Ann D Burnham
Journal:  Diagn Microbiol Infect Dis       Date:  2012-09-07       Impact factor: 2.803

View more
  7 in total

1.  Population Dynamics of Staphylococcus aureus in Cystic Fibrosis Patients To Determine Transmission Events by Use of Whole-Genome Sequencing.

Authors:  Andrea Ankrum; Barry G Hall
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

2.  Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.

Authors:  Marianne S Muhlebach; Sonya L Heltshe; Elena B Popowitch; Melissa B Miller; Valeria Thompson; Margaret Kloster; Thomas Ferkol; Wynton C Hoover; Michael S Schechter; Lisa Saiman
Journal:  Ann Am Thorac Soc       Date:  2015-06

3.  Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor.

Authors:  Sachinkumar B Singh; Amanda J McLearn-Montz; Francesca Milavetz; Levi K Gates; Christopher Fox; Logan T Murry; Ashley Sabus; Harry S Porterfield; Anthony J Fischer
Journal:  Pediatr Pulmonol       Date:  2019-04-22

4.  Polyclonality, Shared Strains, and Convergent Evolution in Chronic Cystic Fibrosis Staphylococcus aureus Airway Infection.

Authors:  Dustin R Long; Daniel J Wolter; Michael Lee; Mimi Precit; Kathryn McLean; Elizabeth Holmes; Kelsi Penewit; Adam Waalkes; Lucas R Hoffman; Stephen J Salipante
Journal:  Am J Respir Crit Care Med       Date:  2021-05-01       Impact factor: 21.405

5.  Long-Term Intrahost Evolution of Methicillin Resistant Staphylococcus aureus Among Cystic Fibrosis Patients With Respiratory Carriage.

Authors:  Taj Azarian; Jessica P Ridgway; Zachary Yin; Michael Z David
Journal:  Front Genet       Date:  2019-06-12       Impact factor: 4.772

6.  Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosis.

Authors:  Deirdre Gilpin; Lucas R Hoffman; Agathe Ceppe; Marianne S Muhlebach
Journal:  J Cyst Fibros       Date:  2021-06-06       Impact factor: 5.482

7.  Incidence and treatment of methicillin-resistant S. aureus infection in cystic fibrosis patients: a cohort study.

Authors:  Paloma Horejs Bittencourt; Carlos Sidney Silva Pimentel; Bianca Sampaio Bonfim; Paulo José Marostica; Edna Lúcia Souza
Journal:  Braz J Infect Dis       Date:  2016-10-15       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.